Five-Year Mortality, Overdose, and Hepatic Outcomes Associated with Prompt Direct-Acting Antiviral Therapy in Adults with Opioid Use Disorder and Chronic Hepatitis C: A Propensity-Matched Cohort Study

Conference Reports for NATAP

The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025


Five-Year Mortality, Overdose, and Hepatic Outcomes Associated with Prompt Direct-Acting Antiviral Therapy in Adults with Opioid Use Disorder and Chronic Hepatitis C: A Propensity-Matched Cohort Study

	AASD 2026 Denver < EzzElDien A. Ibrahim1, Mahmoud Majed Mansour1, Nourhan Saleh1, Mohamed A. Omar1, Mostafa Adel T. Mahmoud2, Akram Alnounou3, Nour, Aldin T. Ahmed2, Youssef Hafez4, Mohammad Alabbas5, Nathan D. Tofteland6